We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $824M
1-Year Est. Return 78.19%
This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+78.19%
3 Year Est. Return
+156.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+388.18%
AUM
$524M
AUM Growth
+$32.8M
Cap. Flow
-$6.68M
Cap. Flow %
-1.28%
Top 10 Hldgs %
32.2%
Holding
157
New
6
Increased
38
Reduced
96
Closed
8

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$3.58M
2
ITRI icon
Itron
ITRI
+$1.9M
3
LLY icon
Eli Lilly
LLY
+$1.83M
4
LNN icon
Lindsay Corp
LNN
+$1.79M
5
EME icon
Emcor
EME
+$1.22M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.98M
2
ECF
Ellsworth Growth & Income Fund
ECF
+$2M
3
ADM icon
Archer Daniels Midland
ADM
+$1.97M
4
DAR icon
Darling Ingredients
DAR
+$1.65M
5
PGJ icon
Invesco Golden Dragon China ETF
PGJ
+$1.61M

Sector Composition

Rank Sector Weight
1 Healthcare 24.97%
2 Industrials 18.64%
3 Technology 16.95%
4 Utilities 10.14%
5 Energy 9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$646B
$29.5M 5.62%
321,721
+2,625
+0.8% +$242K
XOM icon
2
ExxonMobil
XOM
$644B
$23.6M 4.5%
232,934
+7,734
+3% +$715K
GLW icon
3
Corning
GLW
$128B
$22.9M 4.37%
1,283,908
-33,078
-3% -$545K
EMR icon
4
Emerson Electric
EMR
$86.6B
$17M 3.24%
242,205
+40
+0% +$2.67K
KO icon
5
Coca-Cola
KO
$386B
$14.1M 2.69%
340,982
+8,524
+3% +$336K
INTC icon
6
Intel
INTC
$473B
$13.3M 2.55%
514,031
+4,550
+0.9% +$110K
BMY icon
7
Bristol-Myers Squibb
BMY
$136B
$13M 2.47%
243,722
-58,542
-19% -$2.98M
PLL
8
DELISTED
PALL CORP
PLL
$12.9M 2.45%
150,611
-7,353
-5% -$598K
SLB icon
9
SLB Ltd
SLB
$85.1B
$11.9M 2.27%
131,734
-15,090
-10% -$1.36M
MRK icon
10
Merck
MRK
$366B
$10.7M 2.04%
223,417
+12,767
+6% +$584K
IBM icon
11
IBM
IBM
$222B
$10.6M 2.03%
59,207
+20,779
+54% +$3.58M
PFE icon
12
Pfizer
PFE
$159B
$10.4M 1.99%
358,282
-14,365
-4% -$418K
GSK icon
13
GSK
GSK
$102B
$10.2M 1.94%
152,285
-2,899
-2% -$188K
MSFT icon
14
Microsoft
MSFT
$3.81T
$9.79M 1.87%
261,684
-4,300
-2% -$156K
GXP
15
DELISTED
Great Plains Energy Incorporated
GXP
$9.75M 1.86%
402,200
-35,750
-8% -$844K
IDA icon
16
Idacorp
IDA
$7.85B
$9.46M 1.81%
182,475
-2,500
-1% -$128K
GVA icon
17
Granite Construction
GVA
$5.44B
$9.42M 1.8%
269,392
+7,700
+3% +$242K
HON icon
18
Honeywell
HON
$68.9B
$9.13M 1.74%
111,244
-3,784
-3% -$296K
MMM icon
19
3M
MMM
$89.9B
$8.87M 1.69%
75,655
-1,553
-2% -$165K
AMGN icon
20
Amgen
AMGN
$234B
$7.86M 1.5%
68,890
-975
-1% -$111K
BCE icon
21
BCE
BCE
$21.9B
$7.56M 1.44%
174,599
+10,521
+6% +$458K
DUK icon
22
Duke Energy
DUK
$93.8B
$7.04M 1.34%
101,959
-2,873
-3% -$201K
NVS icon
23
Novartis
NVS
$292B
$6.9M 1.32%
95,752
-3,180
-3% -$221K
ADI icon
24
Analog Devices
ADI
$175B
$6.26M 1.2%
123,016
-3,875
-3% -$189K
EXC icon
25
Exelon
EXC
$45.3B
$6.2M 1.18%
317,273
-15,001
-5% -$302K
1
2 3 4 5

Similar funds

SWIG
Strategic Wealth Investment Group Louisville, Kentucky $825M AUM 11.63% 1-Year Est. Return
RP
Rice Partnership Honolulu, Hawaii $824M AUM 40.45% 1-Year Est. Return
WRPWM
Werba Rubin Papier Wealth Management San Jose, California $824M AUM 24.76% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $823M AUM 36.99% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $826M AUM 47.87% 1-Year Est. Return
MGAM
McGowan Group Asset Management Dallas, Texas $823M AUM 27.48% 1-Year Est. Return
HVIA
Hudson Valley Investment Advisors Goshen, New York $823M AUM 31.4% 1-Year Est. Return
MWP
Meridian Wealth Partners Exton, Pennsylvania $826M AUM 21.35% 1-Year Est. Return

John G. Ullman & Associates's Q4 2013 Portfolio in Review

As of Q4 2013, John G. Ullman & Associates held 157 positions worth $524M, up 6.7% from $491M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

John G. Ullman & Associates's Q4 2013 filing shows 6 new, 38 increased, 96 reduced and 8 closed positions. Its largest new stake was Emcor: 31,300 shares worth $1.33M. The largest sale was Bristol-Myers Squibb, an estimated $2.98M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Industrials and Technology.

  • John G. Ullman & Associates's largest Q4 2013 buy was Emcor: 31,300 shares worth $1.33M.
  • John G. Ullman & Associates added most to IBM in Q4 2013, an estimated $3.58M increase.
  • John G. Ullman & Associates's biggest Q4 2013 reduction was Bristol-Myers Squibb, cutting an estimated $2.98M.
  • John G. Ullman & Associates fully exited Darling Ingredients in Q4 2013, selling an estimated $1.65M.
  • John G. Ullman & Associates's ten largest holdings make up 32% of its $524M portfolio in Q4 2013.
  • John G. Ullman & Associates opened 6 new positions and closed 8 in Q4 2013.
  • John G. Ullman & Associates's portfolio value rose 6.7% quarter-over-quarter to $524M.

Based on John G. Ullman & Associates's 13F filing for Q4 2013, filed 3 Feb 2014.